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Abstract. - Phloeodictines Al-A7 (3a, 3b, 4a, 4b, 4c, 5a, 5b) and phloeodictines C1X2 (6a, 6b), new antibacterial 
and cytotoxic guanidine alkaloids, have been isolated from the sponge Phloeodicryon sp. Their structures were established 
essentially by mass spectrometry utilizing B E  l i e d  scanning and by 2D NMR experiments. 
We have recently reported the structure elucidation of two antibacterial and cytotoxic guanidine derivatives 
containing an unprecedented 6-hydroxy- 1,2,3,4-tetrahydropyrlo[ 1,2-a] pyrimidinum skeleton, phloeodictines 
A (1) and B (2), isolated from the New-Caledonian deep water sponge Phloeodictyon sp.l (family 
Nepheliospongia, order Nepheliospongidae). Further search for bioactive agents from the same sponge resulted 
in the isolation of new structurally related pyrrole[ 1,2-a]pyrimidines named phloeodictines Al-A7 (3a, 3b, 
4a, 4b, 4c, 5a, 5b) and Cl-C2 (6a, 6b). The structures of these compounds were established essentially by 
comparison of their collisionally activated dissociation (CAD) mass spectra obtained ushg FAB ionisation and 
B/E linked scanning2 with those of 1. All compounds exhibited in vitro antibacterial activities and were 
moderately cytotoxic against KB cells. 
The lyophilized sponge was extracted with methanol. The antimicrobial methanolic extract was desalted 
over Amberlite XAD-7 and subsequently subjected to medium pressure reversed-phase liquid chromatography 
(H20-MeOH step gradient). Final purification using preparative and semi-preparative RP-HPLC [Delta-Pak 
C18, MeOH- NaCl (0.2M) -THF, pH adjusted to 2.2 with HCI] yielded a ca 2.6: 1 mixture (3) of phloeodictines 
Al  (3a) and A2 (3b), a ca 2.6:0.7:0.3 mixture 4 of phloeodictines A3 (4a), A4 (4b) and A5 (4c). a ca 1:1.4 
mixture (5) of phloeodictines A6 (Sa) and A7 (5b) and a ca 1:l mixture 6 of phloeodictines C1 (6a) and C2 
(6b) as colorless amorphous solids. Typical yields were 0.55% for 3, 0.02% for 4, 0.02% for 5 and 0.54% 
for 6 (dry weight sponge). 
The UV absorption of mixture 3 was the same as that of the previously reported phloeodictine A (1). 
exhibiting maxima at 224 (E 6700) and 274 (E 2200) nm. The positive ion FAB mass spectrum of 3 revealed 
two M+ peaks at ndz 432 and 418 corresponding to phloeodictine AI (3a) and A2 (3b) respectively. The 
molecular formulas C25H46N50 (M+, i d z  432.3712, A -1.0 mmu) for 3a and C24H44N50 (M+, rdz 
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Fig.1. Major fiagrnentation by B/E CAD of the molecular ions of phloeodictine A (1) 
and phloeodictines A1-A7 (3a, 3b, 4% 4b, 4c, Sa, Sb). 3 3 3  s s  4 3 g  
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Fig. 2. EIMS fragmentation of Sa and 8b. 
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418.3545, A 0.1 (A 0.1 mmu) for 3b, established by HRFABMS, differed only by 14 and 28 amu respectively 
from 1 (C26H4gN50). suggesting that the mass difference could correspond to fewer methylene units in the side 
chains. Since 3a and 3b appeared to be homologues of 1, it was desirable to see if CAD spectra could be used 
to pinpoint the location of the homology. To this end, the product ion mass spectra of the M+ ions of 1,3a and 
3b were acquired. The two major cleavage processes obtained are shown in figure 1. For 1, the mass of the ion 
arising from path a is at d z  114, while the ion from path b appears at d z  3333. Collisional activation of the 
M+ ion of 3a indicates that the N-butylguanidine side chain in 1 is replaced, in 3a, by a N-pentylguanidine 
moiety (ion from path a at d z  128). In the case of 3b, the ion arising from path b cleavage is at d z  305, while 
the ion from path a is unshifted as compared to 1, at d z  114, revealing that the difference between 1 and 3b 
resides in the allyl side chain. 
The 1H and 13C NMR specbal data of 3 (Table 1) further supported the structural assignment of the 
alkaloids. Two different sets of 13C signals were observed, in a ratio of 2.6 to 1, for the guanidine side chain 
methylene groups of 3a and 3b respectively. All other 1H and *3C resonances were virtually unchanged from 
the cotresponding signals of 1. The assignment of all protonated carbons were confirmed by DQIF-COSY4 and 
HMQC experiments. 
Catalytic hydrogenation of 3 led to mixture 7 of the tetrahydroalkaloids 7a and 7b, which were further 
converted using acetyllacetone in HC03Na&O/EtOH (3h, reflux) to mixture 8 of their 4,6-dimethylpyrimidine 
derivatives Sa and Sb, respectively. The HREIMS spectrum of 8 confirmed that Sa and 8b differed by the 
chain lenght at N-l. In addition to the molecular ions (Mf) at d z  500.4305 (C30H54N50, A 2.4 mmu) and 
486.4144 (C2gH52N50, A 2.8 mmu), the spectrum displayed typical fragmentations (Fig. 2) at d z  375.3330 
(C24H43N20. A 4.0 mmu), 361.3191 (C23H41N20, A 2.7 mmu), 330.2283 (ClgH28N50. A 1.0 mmu), 
316.2100 (C17H26N50, A 3.7 mmu), 192, 178, 150 and 136. 
The UV spectrum of mixture 4 was the same as that of 1 and 3, indicative of the same absorbing 
chromophore. The HRFABMS of 4 exhibited two M+ ions at d z  404.3415 (A -2.6 mmu) and 390.3265 (A - 
3.2 mmu) corresponding to the molecular formulas C23H42N50 and C22H40N50, respectively. However, CAD 
spectra led to the identification of two isomers, phloeodictines A4 (4b) and A5 (4c) occumng at m/z 390 and 
differing in the lengths of their guanidine and allyl side chains. This identification is based on the observed 
product ions at m/z 263 and 277 arising from the collisiond activation of the M+ ion at mlrz 390 (Fig. 1). The 
CAD spectrum of the ion at d z  404 displayed the major fragmentations shown in figure 1 (product ions at d z  
277 and 128), allowing to assign the structure of phloeodictine A4 (4a). The 1H and 13C NMR spectra of 4 
were almost identical to those of 3, in agreement with the proposed structures 4a, 4b and 4c. 
The UV spectrum of mixture 5 was the same as those of 1 , 3  and 4. The FAB mass spectrum of 5 
showed two M+ peaks at mdz 448 and 434. The molecular formulas C26H50N50 (Mf, d z  4418.4003, A 1.2 
mmu) for phloeodictine A6 (5a) and C25H4gN50 (M+, m/z 434.3848, A 1.1 mmu) for phloeodictine A7 (5b) 
were deduced from HRFABMS. On the basis of the information obtained from the CAD spectra of both 
molecular ions (Fig. l), the difference of 14 amu between Sa and 5b could be located in the guanidine side 
chain. Comparison of the 1H and I3C NMR data of 5 with those of 4 revealed that the molecules were almost 
identical, the only difference being the absence, in 5, of the signals due to the allyl group [6, 139.9 (d) and 
115.4 (t); 6~ 5.80 (ddt, IH), 5.01 (dd, 1H) and 4.92 (dd, lH)] and their replacement by signals at 6,23.1 (t. 
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2C) and 29.l(d) and 6s 0.88 (d) due to a terminal isopropyl group. The structures of phloeodictines A5 and A6 
were, consequently, concluded to be Sa and 5b respectively. 
The UV spectrum of 6 exhibited a maximum at 219 run (E 9100) suggesting the presence of a distinct U V  
chromophore than the previously described phloeodictines. The FAB mass spectrum of 6 contained two weak 
M+ peaks at d z  551 (12%) and 537 (5%). The molecular formulas C28H55N80S (M+, d z  551.4220, A 0.0 
mmu) for phloeodictine CI (6a) and C27HyjNgOS (M+, d z  537.4083, A -2.0 mmu) for phloeodictine C2 (6b) 
were established by HRFABMS. Elemental analysis (S, Cl) confirmed the presence of sulfur and indicated that 
the compounds were isolated as trichloride salts. 
Comparison of the 1H and 13C NMR spectra of 6 with those of phloeodictine BI (2) showed that ring B 
87.8 double bond [6c 170.0 (s) and 108.8 (d); 6s 6.95 (s)] had been replaced by a methylene resonance at 6c 
38.9 (t, C-8) and 6s 3.80 (m, H-8a) and 3.17 (m, H-8b) and by a methine signal at 6c 46.3 (C-7) associated 
with a proton multiplet at 6H 3.65. An additional difference lay in the presence of two sets of 13C resonances, in 
a ratio of 1 to 1, corresponding to the guanidine side chain methylene groups of 6a and 6b (Tables 2 and 3, 
respectively). The remainder of the spectra were essentially identical with those of 2. Evaluation of the HMQC 
spectrum of 6, together with comparison of the COSY5 and HOHAHA6 correlations with those of 2, allowed 
the substitution pattem about the pyrrolo[1,2-a]pyrimidine ring to be confirmed. Finally, analysis of the HMBC 
spectrum (Tables 2 and 3) led to the assignment of structures 6a and 6b for phloeodictines CI and C2, 
respectively. Particularly relevant were the correlations observed between H-7 (6 3.65) and C-26 (6 31.6) as 
well as the complementary cross peak between H-26 (6 2.79) and C-7 (6 46.3), thus establishing the 
connectivity of the sulfur side chain at position 7. However, no NOE correlations were observed and the 
stereochemistry at C-7 was not determined. 
The structure of the sulfur side chain was also supported by diagnostic peaks in the HRFAB mass 
spectrum of 6 at mfz 432.3712 (C25H46N50, A -1.0 mmu) and m/z 418.3545 (C24H44N50, A 0.1 mmu) 
formed by the loss of (NH2)NH=C-NH(CH2)2-SH from the molecular ions of 6a and 6b, respectkely. The 
CAD spectra of the M+ ions of 6a and 6b (Fig. 3) provided confirmation of this fragmentation (produkt ions at 
d z  432 and 418). Moreover, collisional activation of the positive ions at mfz 432 and 418 yielded fragmentation 
pattems similar to those observed for the molecular ion of phloeodictines Al  (3a) and A2 (3b), respectively, 
thus confirming that the difference of one methylene unit between 6a and 6b resided in the guanidine side chain 
moiety. 
of the radical NHz(NH=)C-NH-(CH2)z-S' (12) which could be formed as suggested in scheme 17,*,9. 
Mixtures 3, 4, 5 and 6 have been tested against several bacteria using the standard microdilution plate 
assay and were found to possess a wide spectrum of activity with the following respective MIC's (pg/ml): 
Staphylococcus aureus (3, 30, 1, 3), Escherichia coli (3, 30,3, >30), Pseudomonas aeruginosa (30, >30, 30, 
>30), Clostridium perffingens (30, >30, 1, >loo), Bacteroides fragilis (IO, >30, 3, >loo) and Peptococcus 
assaccharolyricus (IO, >30,3, >loo). These substances also exhibited in vitro cytotoxicity towards KB human 
nasopharyngeal carcinoma cells with IC~O'S of 2.2,3.5,0.6 and 1.8 pg/ml for 3, 4,s and 6 respectively. 
Alkaline treatment of 6 afforded the disulfide 9. Compound 9 most probably results from the dimerisation 
3 
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Fig. 3. Fragmentation by B E  CAD of the molecular ions of phloeodictines C1 ( e a )  
andC2 (6b) .  , 
Scheme 1 
c 
x 
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intemal standard. 2D-NMR experiments were performed with standard pulse sequences. HPLC was carried out 
on Waters Associated instruments. Elemental analyses were performed at the ICSN, CNRS, Gif-sur-Yvette, 
France. 
Extraction und isolation. Specimens of Phloeodictyon sp. (1.5 Kg fresh weight) were collected, 
extracted and desalted as described earlierl. The desalted active fraction (18.5 g) was chromatographed under 
RP medium-pressure liquid chromatography by using a C-18 stationary phase (55-105 pm, 25 cm x 30 mm) 
and a step gradient of HzO-CH~OH as eluent. Purification was achieved by repetitive preparative and semi- 
preparative HPLC using Waters Delta Prep 3000 chromatography system [Delta-Pak C-18, 15 p, 100 A, 47.0 
mm x 30.0 cm, flow rate 100 mllmin followed by final purification on Delta-Pak C-18, 15 p, 100 A, 25.0 mm x 
10.0 cm, flow rate 8 mllmin, UV double detection at 230 and 280 nm, eluent MeOH-NaCI (0.2M) -THF ’ 
(56:43:1 followed by 66:33:1, pH adjusted to 2.2 with HCl), to afford, in order of increasing polarity, mixtures 
4 (9 mg), 6 (244 mg), 3 (250 mg) and 5 (11 mg) as amorphous solids. 
Mixture 3 of phlocodictines AI (3a) und A2 (3b). UV (MeOH) Am, 224 (E 6700) and 274 
(2200) nm; FTIR (film) u- 3400-3100,3019,2928,2855, 1665, 1589, 1462 cm-1 ; FABMS d z  432 (M+, 
IOO), 418 (M+, 38), 305 (27), 128 (48), 114 (73); HRFABMS m/z 432.3712 (C25H460N~ requires 
432.3702), 418.3545 (C24H~0N5 requires 418.3545); CAD spectrum of d z  432 d z  415,414, 390, 305, 
128 ; CAD spectrum of d z  418 d z  401,400,357,305, 114; CAD spectrum of d z  128 d z  111.86; CAD 
spectrum of rdz 114 d z  97,72. 1H and 13C NMR : Table 1. 
Mixture 4 of phloeodictines A3 (44 ,  A4 (4b) and A5 ( 4 4 .  UV (MeOH) Amax 224 (E 6700) 
and 274 (2200) nm; FTIR (film) Um, 3400-3100, 2928, 2850, 1665, 1589, 1462 cm-1 ; FABMS d z  404 
(M+, loo), 390 (Mf 38), 128 (48), 114 (73); HRFABMS m/z 404.3415 (C23H42N50 requires 404.3389), 
390.3265 (C22H40N50 requires 390.3233); CAD spectrum of d z  404 d z  387,386, 362,345, 277, 128; 
CAD spect”  of d z  390 d z  372, 277, 263, 128, 114; CAD spectrum of m/z 128 d z  111, 86; CAD 
I spectrum of m/z 114 d z  97, 72; *H NMR (CD30D) for 4a : 6 5,80 (CH2-CB=CH2, ddt, J = 10, 17 and 7 
Hz), 5.01 (CH2-CH=C&Hb, dd, J = 2,17 Hz), 4,92 (CHz-CH=C=, dd, J = 2,lO Hz), 3.62 (H-9’ and H- 
2, m), 3.55 (H-4a, m) 3.20 (H-4b and H-13’, m), 2.20 (H-3a, m), 2.05 (H-3b, H-14a and C&-CH=CH2, 
m), 1.74 (H-10 and H-l4b, m), 1.62 (H-12’, m). 1.45 (H-11’. m). 1.32 (H-16 to H-20, br s); 1.14 (H-15, 
m); lH NMR (CD30D) for 4b : same as for 4a except 6 3.62 (H-9 and H-2, m), 3.20 (H-4b and H-12, m). 
1.74 (H-10 and H-14b, m), 1.62 (H-12, m); IH NMR (CD30D) for 4c : same as for 4a except 6 1.32 (H-16 
to H-19, br s); 13C NMR (D20) for 4a : 6 160.2 (C-8a), 157.9 (C-14’), 153.2 (C-7), 141.6 (CHz-CH=CH2), 
120.7 (C-X), 115.2 (CHZ-CHZGH~), 98.8 (C-6), 53.3 (C-93, 46.5 (C-2), 42.0 (C-13’), 36.9 (C-4), 34.8 (C- 
14), 34.3 cH2-CH=CH2), 29.4 (C-16 to C-20), 28.8 (C-lo’), 28.0 (C-12’), 24.0 (C-15), 23.7 (C-11’). 20.0 
(C-3); 13C NMR (D20) for 4b : same as for 4a except 6 157.9 (C-13), 53.2 (C-9), 42.0 (C12), 26.2 (C-lo), 
26.2 (C-1 l);13C NMR (D20) for 4c : same as for 4a except 6 29.4 (C-16 to C-20). 
Mixture 5 ofphloeodictines Ad (5u) und A7 (5b). UV (MeOH) hm, 224 (E 6800) and 274 
(2400) nm; FTIR (film) Um, 3400-3100,2928,2850, 1665, 1589, 1462 cm-1 ; FABMS d z  448 (M+, 38), 
434 (M+, 53), 321 (20), 128 (17), 114 (100); HRFABMS mdz 448.4003 (C24H5,NsO requires 448.4015), 
434.3848 (C23H48Ns0 requires 434.3859); CAD spectrum of mdz 448 d z  431,430,406, 387, 321, 128; 
CAD spectrum of mdz 434 d z  417, 416, 373, 321, 114; CAD spectrum of m/z 128 mdz 111, 86; CAD 
spectrum of mdz 114 mdz 97,72; IH NMR (CD30D) for Sa : 6 7.30 (H-7, d, J = 6.5 Hz), 7.05 (H-8, d, J = 
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T m L E  1. 13C (H2Q62SMHz) and 1H (CDCl3,400 MHz) NMR Data 
of Phloeodictines Al  (3a) and A2 (3b) 
Position 6 l3C (m) 6 1H (m, J , Hi 
2 46.6 (t) 
3 20.1 (t) 
4 37.0 (t) 
6 
7 
8 
Sa 
9 '  
10" 
11' 
12' 
13' 
91.4 (s) 
153.0 (d) 
121.0 (d) 
160.0 (s) 
53.6 (t) 
28.8 (t) 
24.1 (t) 
28.4 (t) 
42.2 (t) 
14' 157.9 (s) 
14 36.0 (t) 
15 24.8 (t) 
16-22 30.9-30.1 (t) 
C&-CH=CHz 34.8 (t) 
3.62 (m) 
a 2.20(m) 
b 2.05 (m) 
a 3.55 (m) 
b 3.25 (m) 
7.301 (d, 6.5) 
7.05 (d, 6.5) 
3.62 (m) 
1.76 (m) 
1.45 (m) 
1.65 (m) 
3.30 (m) 
a2.05 (m) 
b 1.76 (m) 
1.15 (m) 
1.25-1.35 (br 
2.051 (m) 
CHZ-CBCHZ 139.8 (s) 5.80 (ddt, 10,17,; 
CHz-CH=- 115.4 (t) a 5.01 (dd, 2, 17) 
b 4.92 (dd, 2, 10: 
Position 6 1 3 ~  (m) 6 1~ (m, J , HZ) 
2 46.7 (t) 3.62 (m) 
3 20.1 (t) a 2.20 (m) 
b 2.05 (m) 
4 
6 
7 
8 
Sa 
9 
10 
11 
12 
13 
14 
37.0 (t) 
98.4 (s) 
153.0 (d) 
121.0 (d) 
160.0 (s) 
53.2 (t) 
26.2 (t) 
26.0 (t) 
42.0 (t) 
157.9 (s) 
a 3.55 (m) 
b 3.25 (m) 
7.30 (d, 6.5) 
7.05 (d, 6.5) 
3.62 (m) 
1.76 (m) 
1.65 (m) 
3.25 (m) 
36.0 (t) a 2.05 (m) 
b 1.76 (m) 
15 24.8 (m) 1.15 (m) 
16-22 30.9-30.1 (t) 1.25-1.35 (br s) 
&-CH=CHz 34.8 (t) 2.05 (m) 
CH2-CH=m 115.4 (t) a 5.01 (dd, 2, 17) 
b 4.92 (dd, 2, 10) 
CHz-&I=CH2 139.8 (s) 5.80 (ddt, 10,17,7) 
EXPERIMENTAL 
General. UV spectra were recorded on a Shimadzu UV-160 spectrophotometer; IR on a Nicolet 205 
FT-IR spectrometer; EIMS (70 eV) on a Kratos MS 50; HREIMS, FABMS (bombardment gas : xenon; matrix : 
glycerol + HC1) and B E  linked scan spectra on a Kratos MS 80. Collisional activation was obtained using argon 
as collision gas; the collision gas pressure was set to give a 30% attenuation of the parent ion beam measured at 
the final collector. HRFABMS were acquired on a VG-ZAB-SEQ spectrometer; NMR on Bruker AM 250 ('H 
and 13C NMR spectra) and AM 400 (1H and 2D-NMR spectra). All NMR spectra were recorded with TMS as 
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6.5 Hz), 3.70 (H-9' and H-2, m), 3.55 (H-4a, m), 3.25 (H-4b and H-13', m), 2.22 (H-3a, m), 2.00 (H-3b 
and H-14a, m), 1.79 (H-lo' and H-l4b, m), 1.65 (H-IT, m), 1.45 (H-ll'), 1.30 (H-16 to H-23, br s),  1.14 
(H-15, m), 0.90 ( C m a ,  d); 1H NMR spectrum for 5b : same as for 5a except 6 3.70 (H-9 and H-2, m), 
3.25 (H-12 and H-4b, m), 1.79 (H-10 and H-14b, m), 1.65 (H-11, m); l3C NMR (D20) for 5a : 6 160.2 (C- 
Sa), 158.1 (C-l4'), 153.2 (C-7), 121.1 (C-8). 98.8 (C-6), 53.6 (C-9'). 46.6 (C-2), 42.2 (C-13'), 40.1 (C- 
23). 37.4 (C-4), 35.4 (C-14), 31.1-30.5 (C-16 to C-22), 29.1 GHMe2.l. 28.5 (C-lo'), 28.2 (C-lT), 24.8 (C- 
E) ,  24.1 (C-ll'), 23.1 ( C ~ A ) ,  20.0 (C-3); 13C NMR (D20) for 5b : same as for 5a except 6 158.1 (C- 
Mixture 6 ofphloeodictines CI (du) und C2 (6b). UV (MeOH) hmm 219 nm (E 9400) ; FTIR 
(film) Umm 3400-3100, 3019,2855, 1668, 1462 cm-1; FABMS d z  551 (M+, 3 , 5 3 7  (MI, lo), 432 (48), 
418 (37) 305 (14), 128 (27). 114 (54); HRFABMS ndz 551.4220 (C28H55NgOS requires 551.4220), 
537.4083 (C27H53N80S requires 537.4063), 432.3712 (C25H46N50 requires 432.3702), 418.3545 
(C24H~N50 requires 418.3546); Anal. Calcd for C ~ ~ . ~ H ~ ~ N S O S ,  3HC1: , 5.0; C1, 16.5. Found: S, 4.9; C1, 
16.3; CAD spectrum of d z  551 ndz 432; CAD spectrum of d z  537 ndz 418; CAD spectrum of d z  432 ndz 
415,414,401,390,371,305,238, 128; CAD spectrum of d z  418 ndz 401,400,357,305,224, 114; CAD 
spectrum of d z  128 d z  11 1,86; CAD spectrum of d z  114 d z  97,72; 1H and 13C NMR : Tables 2-3. 
Mixture 7 of hydrogenation derivatives 7u und 7b. A methanolic solution (15 ml) of 3 [70 mg, 
10% PdC (Ca 40 mg) was shaken for 3 h under an atmosphere of hydrogen. After removal of the catalyst and 
the solvent, a mixture of the hydrogenated derivatives 7a and 7b was obtained (60 mg, 86% theoretical yield) 
as a colorless amourphous solid. UV (MeOH) hmm 219 nm (E 9800); FTIR (film) 2) m a  3400-3100, 3019, 
2930,2855, 1668, 1467'cm -1; FABMS d z  436 (M+. 65), 422 (M+, 30); 1H NMR (CD30D) : 6 3.40 (m, 
5H), 3.30 (m, 3H), 3.12 (m, lH), 3.00 (m, lH), 2.19 (m, 2H), 2.00 (m, 2H), 1.84-1.71 (m, 3H), 1.60 (m, 
2H), 1.45 (m, 2H), 1.32 (m, 2H), 1.29-1.20 (m, 16 H), 0.89 (t, 3H); 13C NMR (D20) : 6 164-7 (s), 158.0 
13), 53.3 (C-9), 46.6 (C-2), 42.3 (C-12), 26.2 (C-lo), 26.1 (C-11), 
(s), 98.5 (s), 53.6 (t), 46.0 (t), 38.3 (t), 38.0 (t), 33.1 (t), 32.4 (t), 30.9-30.5 (t, 9 C), 28.9 (t), 28.7 (t), 27.5 
(t). 26.3 (t), 25.2 (t), 24.7 (t), 24.3 (t), 24.3 (t), 23.8 (t), 20.1 (t), 15.0 (9); FABMS ndz 436 (M+, 65) and 
422 (M+, 30). 
Mixture 8 of 4,6-dimethylpyrimidine derivatives 8u und 8b. Mixture 7 (60 mg) was dissolved 
in 95% EtOH (1 ml) and H20 (0.5 ml) containing NaHCO3 (0.04g). Acetylacetone (70 pl) was added and the 
mixture was refluxed for 3 h. The solution was then neutralized with HC1, filtered and evaporated till dryness. 
After removal of NaCl by precipitation in CHClyEtOH (85: 15), filtration and evaporation, the residue was 
purified by chromatography on silica gel eluted with CH2C12-MeOH (8:0.2 to 7:3) affording compounds Sa and 
8b as an inseparable mixture (17 mg, 43% theoretical yield). UV (MeOH) hmm 235 (E 6000) and 299 (1080) 
nm; FTIR (film) U m a  3440-3100, 3019, 2920, 2855, 1658,1588 cm-1; 1H NMR (CDC13) : 6 7.12 
(exchangeable br s, NH), 6.30 (s, IH), 2.50 (br s, 6H); l3C NMR (D20) : 6 167.0 (s, 2C), 163.7 (s), 161.9 
(s), 109.3 (d), 98.1 (s), 52.4 (t), 44.8 (t), 40.4 (t). 37.6 (t), 36.4 (t), 31.5 (t), 31.0 (t), 28.8-29.3 (t, 9 C), 
28.8 (t), 26.6 (t), 23.5 (4. 2C), 23.4 (t), 22.3 (t), 18.6 (t), 13.7 (4); H E I M S  ndz 500.4305 (M+, C,oH++N50 
requires 500.4329), 486.4144 (M+, C29H52N50 requires 486.4172). 375.3330 (C24H43N20 requires 
375.3375),361.3191 ( C ~ ~ H ~ I N ~ O  requires 361.3218), 330.2283 (C18H28N50 requires 330.2293), 3 16.2100 
(C17H26N50 requires 316.21371, 192.1820 (CllH18N3 requires 192.1835), 178.1558 (C10H16N3 requires 
178.1567), 150.1020 (C8H12N3 requires 150.103 I), 136.0872 (C7H10N3 requires 136.0875). 
Phloeodictines Al-A7 and ,Cl-C2 
TABLE 2.13C (62.5MHz) and 1H (400 MHz) NMR Data of P h l d c t i n e  
C1 (6a)a and Long-Range Correlations from HMBC experiments. 
Position 6 13C (m) 6 'H (m, J I  Hz) HMBC (IH) 
2 
3 
4 
6 
7 
8 
Sa 
9 '  
1 O' 
11' 
12' 
13' 
14' 
14 
15 
16-22 
23 
24 
25 
26 
27 
28 
OH 
NH2 
46.5 (t) 
20.1 (t) 
37.9 (t) 
98.5 (s) 
46.3 (d) 
38-9 O) 
164.1 (s) 
29.1 (t) 
24.1 (t) 
27.6 (t) 
42.4 (t) 
158.3 (s) 
36.5 (s) 
24.5 (t) 
34.7 (t) 
53.8 (t) 
29.1-30.2 (t) 
141.5 (d) 
115.5 (t) 
31.6 (t) 
42.2 (t) 
158.3 (s) 
3.48 (m) 
a 2.08 (m) 
b 1.90 (m) 
a 3.48 (m) 
b 3.17 (m) 
3.65 (m) 
a 3.80 (m) 
b 3.17 (m) 
3.48 (m) 
1 3  (m) 
1.52 (m) 
1.52 (m) 
3.17 (m) 
a 1.90 (m) 
b 1.70 (m) 
1.14 (m) 
1.25-1.35 (br s) 
1.90 (m) 
1.70 (m) 
5.80 (ddt, 10,17,7) 
a 5.01 (dd, 2, 17) 
b 4.92 (dd, 2, 10) 
2.79 (m) 
3.48 (m) 
6.90 (s)b 
7.05-7,75 (br sIb 
NH-28 8.02 (br s ) ~  
NH-14' 8.12 (br s ) ~  
H-4a 
H-7, H-Sa, H-14ab 
H-lab, H-26 
H-7 
H-2, H-4a, H-Sab 
H- 13' 
H-12'. 
H-Y, H-11' 
H-11' 
H-13' 
H- 14ab 
H-15, H-23 
H-24 
H-23 
H-23, H-24 
H-7, H-25 
H-26 
H-27 
3423 
ain CD3OD except as noted, bin DMSO-&. 
3425 
I 14 36.5 (s) a 1.90 (m) 
b 1.70 (m) 
16-22 29.1-30.2 (t) 1.25-1.35 (br s) H-15, H-23 
15 24.5 (t) 1.14 (m) H-14ab 
23 ' 34.7 (t) 1.90 (m) H-24 
141.5 (d) 5.80 (ddt, 10,17,7) H-23 
6 
Phloeodictines Al-A7 and C1%2 
TABLE 3. 13C (62.5MHz) and 'H (400 MHz) NMR Data of Phloeodictine 
C2 (6b)a and Long-Range Correlations from HMBC experiments. 
Position 6 13C (m) 6 lH (m, J , Hz) HMBC (IH) 
1 2 46.5 (t) 3.48 (m) H-4a 
3 20.1 (t) a 2.08 (m) 
b 1.90 (m) 
4 37.9 (t) a 3.48 (m) 
b 3.17 (m) 
6 98.5 (s) H-7, H-Sa, H-14ab 
7 46.3 (d) 3.65 (m) H-8ab. H-26 
8 38.9 (t) 
8a 164.1 (s) 
9 53.8 (t) 
10 26.5 (t) 
11 25.3 (t) 
12 42.4 (t) 
13 158.3 (s) 
a 3.80 (m) H-7 
b 3.17 (m) 
3.48 (m) 
H-2, H-4a, H-Sab 
1.70 (m) H-11 
1.52 (m) H-12 
3.17 (m) H-11 
H-12 
0 in CD3OD except as noted; b in DMso-d6. 
3426 
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NOTES 
2,2'-diguanidinodiethyl~isuZ~~~e (9) To a solution of 6 (100 mg) in MeOH (8 mi) was added 
NaOH 8N (1.3 ml) and the mixture was stirred for 16 h at roo temperature. The solution was then neutralized 
with HC1, and after removal of NaCl, the residue was purifi d by CC on reversed phase silica gel (Waters 
Preparative C18 55-105 pm, 2.4 g). Compound 9 (15 mg, 15% theoretical yield) was eluted at first with water: 
FABMS d z  273 [(MH + H35C1)+, (28)], 237 [(MH)+, (%)I, 120 (85), 93 (100); IH NMR (DMSO-&: 6 8.0 
(exchangeable br s, NH), 7.80-7.35 (exchangeable br s, NHz), 3.44 (t. J = 6.5 Hz, CHZ-N), 2.90 (t, J = 6.5 
.. 
Hz, CH2-S); 13C NMR (D20) : 6 158.0 [s, -NH-j3lH(NH2)], 41.0 (t, -CHz-NH- ), 37.3 (t. -CH2-S-). 
25/26,14ab/15, 15/( 16 to 22), (I6 to 22)/23,23/24,24/25ab, 
butylguanidine moiety of 6b and !WO', lO'/ll', 11'/12', 
6. The HOHAHA spectrum of 6 (DMSO-d6) afforded the 
3ab/4ab, 7/8ab, 25/26,14ab/15, 15/(116 to 22), (16 to 22)/23, 
27/NH as well as YJlO', 9'/12', lOYlI', lO'/l2', 11'/12', 
pentylguanidine side chain of 6a and 9/10,9/11, 10/11, 10/12, 
26/27 as well as 9/10, lO/ll, 11/12 for the N- 
12Y113' for the pentylguanidine side chain of 6a. 
fol.owing connectivities (H-H): 2/3ab, 2/4ab, 
23/24, 23/25ab, 24/25ab, 26/21, 26/NH, 
12'/13', 11'/13', 12'INH and 13'INH for the 
11/12, 12/NH, 1 UNH for the N- 
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